|
Post by sportsrancho on Feb 10, 2019 5:25:23 GMT -5
Makes sense to me. So did Al himself really create it? Was he close to or friends with the top powers that make up RLS? Are they paying rent? So it would seem.
|
|
|
Post by mnholdem on Feb 10, 2019 9:05:44 GMT -5
I absolutely think that Alfred E. Mann was instrumental in the creation of Receptor Life Sciences. Whether there are contractual ties to MannKind is unknown but I think that Mann may have had concerns about cannabis and its impact on Afrezza if MannKind were to begin development of cannabis-based therapeutics.
|
|
|
Post by akemp3000 on Feb 10, 2019 9:21:44 GMT -5
The thing that continually jumps out to me is that Al's wife suffered from migraines. With pure speculation, Andrea-Leone Bay may have convinced Al that TS could be the the first ultra-rapid solution for migraine pain...but that cannabinoids was still an undeveloped arena and Mannkind did not have the funds to pursue it as aggressively as Al was pursuing the diabetes sector. Al loved pursing new big challenges so I can imagine him turning to investor friends in Seattle, meeting with Andrea and all of them agreeing to pursue it independently of Mannkind Corporation but with support in every other way possible. This would be comparable to his interest in EYES but with silent support for Andrea and the opportunity. IMO, the agreement in place already covers how the future relationship will unfold and will hopefully lead to revenue, growth and success for both companies without including a merger. Al seemed to be receptive to attractive buyouts but not mergers. I think he recognized that co-mingling sectors was not usually a good business path. I believe the plan has been to keep expenses down until RLS could gain approval and stand alone which could hopefully happen soon. Just my two cents guess.
|
|
|
Post by sayhey24 on Feb 10, 2019 9:36:54 GMT -5
Makes sense to me. So did Al himself really create it? Was he close to or friends with the top powers that make up RLS? Are they paying rent? So it would seem. Interesting question - was Al involved in the initial "pot" discussions? It would not surprise me.
Maybe one day soon we will find out the RLS story and the relationship between the MSFT group and MNKD and how active Kevin Johnson has been besides sending his top marketing guy Arthur Rubinfeld to RLS.
|
|
|
Post by mnkdfann on Feb 10, 2019 10:09:22 GMT -5
ST....@bigcheeze 2/9/19, 8:17 AM @rooksleanne lee143 RLS is a $MNKD shell created by Al Mann.They both have almost identical addresses and same employees & same technology Mannkind officially denied the RLS shell company etc. rumours years ago in a FAQ it published at the time. Goodness knows where that FAQ is now hidden on the Mannkind site, but it still turns up if one googles the words: receptor life sciences faq mannkind license agreement From FAQ: "The licensing agreement is between MannKind and Receptor Life Sciences, Inc., an independent company, not affiliated with MannKind. The company is private and newly formed under this name. We can confirm that the company is funded by an important investor group, supported by prominent business leaders in the Seattle area. Alfred Mann is not an investor or in any way affiliated with Receptor."
|
|
|
Post by sportsrancho on Feb 10, 2019 11:25:07 GMT -5
ST....@bigcheeze 2/9/19, 8:17 AM @rooksleanne lee143 RLS is a $MNKD shell created by Al Mann.They both have almost identical addresses and same employees & same technology Mannkind officially denied the RLS shell company etc. rumours years ago in a FAQ it published at the time. Goodness knows where that FAQ is now hidden on the Mannkind site, but it still turns up if one googles the words: receptor life sciences faq mannkind license agreement From FAQ: "The licensing agreement is between MannKind and Receptor Life Sciences, Inc., an independent company, not affiliated with MannKind. The company is private and newly formed under this name. We can confirm that the company is funded by an important investor group, supported by prominent business leaders in the Seattle area. Alfred Mann is not an investor or in any way affiliated with Receptor." Yes I remember that. I’d call it associated.
|
|
|
Post by lakon on Feb 10, 2019 11:52:57 GMT -5
Mannkind officially denied the RLS shell company etc. rumours years ago in a FAQ it published at the time. Goodness knows where that FAQ is now hidden on the Mannkind site, but it still turns up if one googles the words: receptor life sciences faq mannkind license agreement From FAQ: "The licensing agreement is between MannKind and Receptor Life Sciences, Inc., an independent company, not affiliated with MannKind. The company is private and newly formed under this name. We can confirm that the company is funded by an important investor group, supported by prominent business leaders in the Seattle area. Alfred Mann is not an investor or in any way affiliated with Receptor." Yes I remember that. I’d call it associated. If a lawyer can parse it, and it's legal. I would not doubt it. They were very smart about semantics.
|
|
|
Post by mytakeonit on Feb 10, 2019 16:39:15 GMT -5
They are stand alone companies ... which is good. Easier to make changes in your company or direction ... without having to discuss it with a partner.
Just like I don't have to tell you all about what I plan to do next. Ha!
Wow, it really is a "blustery day" here ... and no HeeHaws please.
|
|
|
RLS
Feb 11, 2019 10:49:49 GMT -5
Post by bigchungus91354 on Feb 11, 2019 10:49:49 GMT -5
I find these moves simply fascinating. What was she told to make the move and what future announcements are pending? You wouldn’t believe how many people have called me tonight, “fascinating” was is the main consensus :-)) So, Receptor is going to acquire MNKD, or are they just poaching employees? They would obviously need to raise a great deal more cash.
|
|
|
RLS
Feb 11, 2019 11:00:59 GMT -5
Omega likes this
Post by akemp3000 on Feb 11, 2019 11:00:59 GMT -5
You wouldn’t believe how many people have called me tonight, “fascinating” was is the main consensus :-)) So, Receptor is going to acquire MNKD, or are they just poaching employees? They would obviously need to raise a great deal more cash. IMO, none of the above. Receptor isn't going to acquire MNKD. They're not poaching employees. It's possible they have serious cash available that hasn't been disclosed just yet.
|
|
|
Post by sportsrancho on Feb 11, 2019 11:07:57 GMT -5
You wouldn’t believe how many people have called me tonight, “fascinating” was is the main consensus :-)) So, Receptor is going to acquire MNKD, or are they just poaching employees? They would obviously need to raise a great deal more cash. I absolutely think that Alfred E. Mann was instrumental in the creation of Receptor Life Sciences. Whether there are contractual ties to MannKind is unknown but I think that Mann may have had concerns about cannabis and its impact on Afrezza if MannKind were to begin development of cannabis-based therapeutics. Read more: mnkd.proboards.com/thread/10936/rls?page=4#ixzz5fEtnOYdmAnd they live rent free. I can’t see any scenario where they bought us .
|
|
|
RLS
Feb 11, 2019 11:21:22 GMT -5
Post by bigchungus91354 on Feb 11, 2019 11:21:22 GMT -5
So, Receptor is going to acquire MNKD, or are they just poaching employees? They would obviously need to raise a great deal more cash. I absolutely think that Alfred E. Mann was instrumental in the creation of Receptor Life Sciences. Whether there are contractual ties to MannKind is unknown but I think that Mann may have had concerns about cannabis and its impact on Afrezza if MannKind were to begin development of cannabis-based therapeutics. Read more: mnkd.proboards.com/thread/10936/rls?page=4#ixzz5fEtnOYdmAnd they live rent free. I can’t see any scenario where they bought us . So Mann Foundation is funding RLS which indirectly benefits MNKD financially, do you think AMF still has a vested interest in supporting the survival of MNKD?
|
|
|
RLS
Feb 11, 2019 12:45:17 GMT -5
Post by bigchungus91354 on Feb 11, 2019 12:45:17 GMT -5
So, Receptor is going to acquire MNKD, or are they just poaching employees? They would obviously need to raise a great deal more cash. I absolutely think that Alfred E. Mann was instrumental in the creation of Receptor Life Sciences. Whether there are contractual ties to MannKind is unknown but I think that Mann may have had concerns about cannabis and its impact on Afrezza if MannKind were to begin development of cannabis-based therapeutics. Read more: mnkd.proboards.com/thread/10936/rls?page=4#ixzz5fEtnOYdmAnd they live rent free. I can’t see any scenario where they bought us . Just the same way that CYTR created Centurion to extract its LADR candidates from the parent company, I suspect MNKD will produce a similar spin-off to extract its Technosphere candidates from the MNKD parent company. This way if Afrezza proves to be a commercial failure and the franchise accumulates significant debt, the rest of the pipeline won't have to sink with that ship. The key question will be what percentage of ownership will current investors get in the spin-off in exchange for the rights to the IP, and will it go public or remain private?
|
|
|
Post by Omega on Feb 11, 2019 13:44:34 GMT -5
Mannkind officially denied the RLS shell company etc. rumours years ago in a FAQ it published at the time. Goodness knows where that FAQ is now hidden on the Mannkind site, but it still turns up if one googles the words: receptor life sciences faq mannkind license agreement From FAQ: "The licensing agreement is between MannKind and Receptor Life Sciences, Inc., an independent company, not affiliated with MannKind. The company is private and newly formed under this name. We can confirm that the company is funded by an important investor group, supported by prominent business leaders in the Seattle area. Alfred Mann is not an investor or in any way affiliated with Receptor."It seems some people missed the post I quoted above that was posted earlier in the thread. "Alfred Mann is not an investor or in any way affiliated with Receptor."Link From Mannkind's Website: www.mannkindcorp.com/Collateral/Documents/English-US/TS%20licensing%20FAQ.pdfWho is the licensing agreement with? The licensing agreement is between MannKind and Receptor Life Sciences, Inc., an independent
company, not affiliated with MannKind. The company is private and newly formed under this name. We can confirm that the company is funded by an important investor group, supported by prominent business leaders in the Seattle area. Alfred Mann is not an investor or in any way
affiliated with Receptor. MannKind did significant diligence in regards to Receptor and its financial backers, and came away quite impressed. But the underlying investors, for good reasons of their own, need not and choose not to disclose their involvement at this time.
|
|
|
RLS
Feb 11, 2019 15:07:09 GMT -5
Post by mnkdfann on Feb 11, 2019 15:07:09 GMT -5
The above FAQ also noted that some Mannkind employees on Mannkind's payroll would be tasked with doing work in support of RLS' activities. I'm sure Mannkind (not exactly rolling in cash to spare) would be more than happy if some or all of those employees were 'poached' by RLS and transferred to the payroll of RLS instead. Perhaps that explains any employee movement to RLS since 2016.
What are MannKind’s responsibilities in the licensing agreement? MannKind is responsible for transferring necessary technical information about the Technosphere platform to the licensee and then providing ancillary support as they develop their product on the Technosphere platform, and ultimately ramp up their manufacturing capability. To support these efforts, MannKind will name a team of existing scientific and manufacturing personnel to work with a corresponding team from the licensee, and a project plan will be implemented to manage the process. We anticipate no incremental costs to MannKind, just the costs of existing personnel.
|
|